MODAG Trademark

Trademark Overview


On Friday, January 31, 2020, a trademark application was filed for MODAG with the United States Patent and Trademark Office. The USPTO has given the MODAG trademark a serial number of 79292215. The federal status of this trademark filing is REGISTERED as of Tuesday, July 20, 2021. This trademark is owned by MODAG GmbH. The MODAG trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical drugs and medicines for the treatment of the nervous system and for the treatment of diseases characterized by pathological protein aggregation; diagnostic preparations for medical purposes

Chemical substances, chemical materials, chemical compositions and chemical preparations, all of the foregoing for use in science

Medical services in the field of diseases characterized by pathological protein aggregation; Medical diagnosis of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; medical services in the field of neurodegenerative diseases; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis, prognosis and treatment of neurodegenerative diseases and diseases characterized by pathological protein aggregation; providing medical data and information in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation to healthcare professionals; rental of medical apparatus and equipment, and fittings therefor

Medical apparatus and instruments for monitoring molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor; Medical diagnostic apparatus for testing molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor

Scientific and technological services, namely, research and design in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; industrial analysis and research services in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; biological research; research and development of new products for others; Conducting clinical trials for others in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; Scientific laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; pharmaceutical drug development services
modag

General Information


Serial Number79292215
Word MarkMODAG
Filing DateFriday, January 31, 2020
Status700 - REGISTERED
Status DateTuesday, July 20, 2021
Registration Number6422358
Registration DateTuesday, July 20, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements


Description of MarkThe mark consists of the wording "MODAG" in a stylized font where the letters "M", "D", "A" and "G" are in dark blue, the letter "O" is grey, and the letters "O" and "G" encircle a green dot.
Description of the Colors ClaimedThe letters M, D, A and G are dark blue, the letter O is grey and the letters O and G encircle a green dot.
Goods and ServicesPharmaceutical drugs and medicines for the treatment of the nervous system and for the treatment of diseases characterized by pathological protein aggregation; diagnostic preparations for medical purposes
Indication of Colors claimedThe color(s) dark blue, green and grey is/are claimed as a feature of the mark.
Goods and ServicesChemical substances, chemical materials, chemical compositions and chemical preparations, all of the foregoing for use in science
Goods and ServicesMedical services in the field of diseases characterized by pathological protein aggregation; Medical diagnosis of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; medical services in the field of neurodegenerative diseases; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis, prognosis and treatment of neurodegenerative diseases and diseases characterized by pathological protein aggregation; providing medical data and information in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation to healthcare professionals; rental of medical apparatus and equipment, and fittings therefor
Goods and ServicesMedical apparatus and instruments for monitoring molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor; Medical diagnostic apparatus for testing molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor
Goods and ServicesScientific and technological services, namely, research and design in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; industrial analysis and research services in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; biological research; research and development of new products for others; Conducting clinical trials for others in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; Scientific laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; pharmaceutical drug development services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMODAG GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameMODAG GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameMODAG GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Monday, February 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, December 19, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 1, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, December 1, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 20, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 20, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Sunday, May 2, 2021NOTIFICATION PROCESSED BY IB
Wednesday, April 14, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 14, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 31, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 19, 2020REFUSAL PROCESSED BY IB
Friday, September 25, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 25, 2020REFUSAL PROCESSED BY MPU
Tuesday, August 25, 2020APPLICATION FILING RECEIPT MAILED
Saturday, August 22, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 21, 2020NON-FINAL ACTION WRITTEN
Friday, August 21, 2020ASSIGNED TO EXAMINER
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 20, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB